INSP Company Profile and Key Details

Inspire Medical Systems, Inc. (NYSE:INSP) closed at $97.93 USD, gaining $1.39 (1.44%) from the previous close of $96.54. The stock is currently mid-range between its 52-week high and low $70.77 and $216.01. With a market capitalization of about $2.90 billion, Inspire Medical Systems, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.70). Key stats such as the average daily volume over the past year has been around 1.52 million shares, in line with its 52-week average. Headquartered in Golden Valley, MN, Inspire Medical Systems, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Timothy Herbert, the company employs approximately 1,246 people and listed since May 03, 2018. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

Short-term trend indicators are mixed aligned (SMA20 -22.73%, SMA50 -2.01%, SMA200 -18.69%). The stock’s 14-day RSI is 38.01 (weak momentum), while the ATR of 9.08 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -55.31% below its high and over 36.41% above its low. Average 10-day trading volume of 2.37 million shares is significantly above the 3-month average of 1.39 million, indicating heightened recent market interest.

Inspire Medical Systems, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$104.63. This means the shares are trading below this model’s fair value.

Wall Street analysts project EPS growth of 12.78% annually over the next five years. The latest quarter delivered EPS of $0.34. The next quarter is forecast at $0.67. Next year's EPS is expected at $51.10. Analyst sentiment is bullish. Analyst rating data shows there are 20 Strong Buy ratings, 5 Buy ratings, 14 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $260.00 to $82.00. The high target offers 169.32% upside. The low target suggests -15.06% downside. The mean target is $155.38. This offers 60.95% upside. Inspire Medical Systems, Inc. earnings surprise history is a mixed track record. The quarter that ended November 03, 2025, missed forecasts by -323.67%. The prior quarter beat by 104.55%. Over the last six quarters, Apple has recorded several small beats. These include -328.57% in August 06, 2024.

Inspire Medical Systems, Inc. has 29.57 million shares outstanding. The public float is 26.74 million shares, elevated short interest at 11.40% of float. This equals 2.51 million shares. The short ratio is 4.3 days. Institutional investors hold 118.97% of the float. Insiders own 1.14%. NELSON MARILYN C holds 74.10 thousand shares, Herbert Timothy P. has 63.66 thousand shares and Buchholz Richard has 44.87 thousand shares. Over the past six months, insider transactions show net selling. They sold 14.20 thousand shares across 4 transactions.

Our AI price prediction model suggests that Inspire Medical Systems, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 21.47%, with price expected at $117.27 by January 02, 2026, within a range of $100.77 to $131.61 3-Month Outlook: Projected rise of 120.26%, reaching $212.64 by March 19, 2026, with a range of $187.07 to $236.11. 1-Year Outlook: Projected loss of -81.26%, with price at $18.09 by December 18, 2026, within a range of $3.71 to $30.35.

Inspire Medical Systems, Inc. (NYSE:INSP) shares are down -47.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Inspire Medical Systems, Inc. trading at a premium to the broader market with a P/E of 53.69. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $200.36, suggesting 107.54% upside. Our AI forecast model points to short-term strength (21.47% over two weeks), a medium-term rise (120.26% over three months), and a longer-term loss (-81.26% over one year), with expected trading ranges indicating moderate volatility.